Weisblum Eric 4
4 · Silo Pharma, Inc. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Purchase
Common Stock
2023-12-14$1.50/sh+200$300→ 168,324 total - Purchase
Common Stock
2023-12-15$1.52/sh+900$1,368→ 169,224 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.52. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.